Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
35
NMPA:35
Drug Approvals
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets（Ⅰ）
- Product Name
- 沙格列汀二甲双胍缓释片(Ⅰ)
- Approval Number
- 国药准字H20254230
- Approval Date
- May 20, 2025
NMPA
Indapamide Sustained Release Tablets
- Product Name
- 吲达帕胺缓释片
- Approval Number
- 国药准字H20253856
- Approval Date
- Apr 8, 2025
NMPA
Isosorbide Mononitrate Sustained-release Tablets
- Product Name
- 单硝酸异山梨酯缓释片
- Approval Number
- 国药准字H20249430
- Approval Date
- Nov 22, 2024
NMPA
Acetylcysteine Granules
- Product Name
- 乙酰半胱氨酸颗粒
- Approval Number
- 国药准字H20249427
- Approval Date
- Nov 22, 2024
NMPA
Azithromycin Dispersible Tablets
- Product Name
- 阿奇霉素分散片
- Approval Number
- 国药准字H20093302
- Approval Date
- Oct 25, 2023
NMPA
Pantoprazole Sodium for Injection
- Product Name
- 注射用泮托拉唑钠
- Approval Number
- 国药准字H20083982
- Approval Date
- Mar 23, 2023
NMPA
Compound Tranilast Tablets
- Product Name
- 复方曲尼司特片
- Approval Number
- 国药准字H20080679
- Approval Date
- Mar 23, 2023
NMPA
Nifedipine Sustained-release Tablets（II）
- Product Name
- 硝苯地平缓释片(Ⅱ)
- Approval Number
- 国药准字H20223905
- Approval Date
- Nov 30, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found